A pharmacological review on intraperitoneal chemotherapy for peritoneal malignancy

doi:10.4251/wjgo.v2.i2.109

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 2, Issue 2

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6148)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-8) series, Tables (1-1) series.

Item

Count

PDF

573

HTML

5324

Figures (1-8)

138

Tables (1-1)

113

Sum=6148

Feb 15, 2010 (publication date) through Apr 26, 2024

Times Cited of This Article

Times Cited (57)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastrointest Oncol. Feb 15, 2010; 2(2): 109-116
Published online Feb 15, 2010. doi: 10.4251/wjgo.v2.i2.109

Full Size Figure Download Figure

Figure 8 Mean total drug remaining in peritoneal cavity at 23 h. Hypertonic carrier solutions maintain the artificial ascites and paclitaxel concentrations, during early postoperative intraperitoneal paclitaxel instillation. Cite from reference[45].

Citation: Yan TD, Cao CQ, Munkholm-Larsen S. A pharmacological review on intraperitoneal chemotherapy for peritoneal malignancy. World J Gastrointest Oncol 2010; 2(2): 109-116
URL: https://www.wjgnet.com/1948-5204/full/v2/i2/109.htm
DOI: https://dx.doi.org/10.4251/wjgo.v2.i2.109